Activation of MAPK and AKT/mTOR pathways was found in a series of uveal melanomas (Populo et al., 2010), but in those cancers this activation did not relate with the presence of GNAQ mutation (Populo et al., 2011b). The gene discussed is MTOR; the disease is cancer.